Business How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? Last updated: August 5, 2026 7:33 pm By admin Share 0 Min Read SHARE Please enable JS and disable any ad blocker Share This Article Email Copy Link Print Previous Article 6 contech startups net $234M in recent funding Next Article Stopgap transportation funding fails to advance in Senate Leave a Comment Leave a Reply Cancel replyCommentNameEmailWebsite Turn on JavaScript to leave a comment. FacebookLikeXFollowInstagramFollowLinkedInFollowMediumFollowRSS FeedFollow Most Read McDonald’s just introduced the US to its most popular international menu items. Here are the ones you should order and avoid. Bstocks Tokenized Equity Market Share Hits 27% in Two Months Uber shares slip after the company’s operating and marketing chiefs reportedly step down BaiBai launches as first PropAMM aggregator on Base, promising to pay double if you find a better price IEOs Raise Half a Billion, Keep Fundraising Alive for Blockchain Startups Injective Ranks 4th as L1 Revenue Gains More Focus One of Lyft’s early investors explains why he opted for the smaller company over Uber, and which growth metrics he’ll be watching in the coming quarters Putin says Russia, North Korea coordinating on regional security 10 things you need to know before the opening bell Complaints filed against Sonia Gandhi in Delhi, Karnataka over ‘Vande Mataram’ row at Congress headquarters